Skip to main content
. 2022 Jan 14;12:731187. doi: 10.3389/fendo.2021.731187

Table 2.

Comparison of clinical findings in T2DM with renal impairment according to renal resistance index.

Parameters R I< 0.66 (n = 213) RI ≥ 0.66 (n = 256) P value
Age, (years) 49.20 ± 10.47 53.37 ± 9.64 <0.001
Gender, (male, %) 132(61.97) 166 (64.84) 0.526
BMI, (kg/m2) 25.67 ± 3.64 24.87 ± 3.31 0.013
SBP, (mm Hg) 136.73 ± 20.47 147.62 ± 23.17 <0.001
DBP, (mm Hg) 84.92 ± 11.53 83.96± 12.69 0.398
Duration of diabetes, (months) 51.46 ± 55.12 95.69 ± 61.01 <0.001
Duration of diabetes ≥ 60, months (%) 70 (32.86) 169(66.01) <0.001
HbA1c, (%) 7.70 ± 1.88 7.94 ± 2.33 0.284
HbA1c ≥ 7, (%) 97(45.54) 118 (46.09) 0.832
FBG, (mmol/L) 7.17 ± 3.08 7.48 ± 3.54 0.313
Hemoglobin, (g/L) 126.00 ± 23.53 110.60 ± 23.95 <0.001
PLT, (10^9/L) 211.45± 82.92 200.98 ± 76.00 0.157
Serum albumin, (g/L) 36.13 ± 10.45 34.26 ± 8.37 0.034
TG, (mmol/L) 2.44 ± 1.97 2.03 ± 1.75 0.018
TC, (mmol/L) 5.47 ± 2.24 5.48 ± 1.75 0.920`
Scr, (μmol/L) 106.47± 60.54 144.76 ± 83.96 <0.001
eGFR, (ml/min/1.73m2) 79.03 ± 35.72 59.22 ± 32.71 <0.001
BUN, (mmol/L) 7.01 ± 3.21 8.56 ± 3.90 <0.001
Uric acid, (μmol/L) 375.98 ± 103.04 381.33 ± 91.05 0.555
Urinary protein, (g/24 h) 3.03 ± 3.96 3.73 ± 3.47 0.054
Hematuria (%) 134 (62.91) 184 (71.88) 0.056
Cardiovascular disease (%) 78 (36.61) 101 (39.45) 0.479
Hypertension (%) 121 (56.81) 191 (74.61) 0.003
DR (%) 63 (29.58) 163 (63.67) <0.001
Nephrotic syndrome (%) 40 (18.78) 69 (26.95) 0.037

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycosylated hemoglobin; FBG fasting blood glucose; PLT, platelet; TG triglyceride; TC total cholesterol; Scr serum creatine; BUN blood urea nitrogen; DR, diabetic retinopathy. Data were presented as the mean ± standard, the median with range or counts and percentages. A two-tailed p < .0.05 was considered statistically significant.